[Pancytopenia following pyrimethamine treated to toxoplasmosis].
D000328:Adult; D000741:Anemia, Aplastic / Q000139:chemically induced* / Q000473:pathology; D005260:Female; D005492:Folic Acid / Q000627:therapeutic use; D005494:Folic Acid Deficiency / Q000188:drug therapy; D006474:Hemorrhagic Disorders / Q000139:chemically induced; D006801:Humans; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy*; D011739:Pyrimethamine / Q000009:adverse effects*; D014123:Toxoplasmosis / Q000188:drug therapy*
D005492:Folic Acid; D011739:Pyrimethamine
Panzytopenie nach Pyrimethaminbehandlung bei Toxoplasmose.